1. 894. Patient and Surgery Characteristics on Wound Complication and Surgical Site Infection in Sarcoma Patients undergoing Hemipelvectomy. (31st December 2020) Authors: Katzman, Ju Hee; Sun, Steven; Joyce, David; Greene, John Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials—Application of the Estimand Framework. (1st October 2020) Authors: Degtyarev, Evgeny; Rufibach, Kaspar; Shentu, Yue; Yung, Godwin; Casey, Michelle; Englert, Stefan; Liu, Feng; Liu, Yi; Sailer, Oliver; Siegel, Jonathan; Sun, Steven; Tang, Rui; Zhou, Jiangxiu Journal: Statistics in biopharmaceutical research Issue: Volume 12:Number 4(2020) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer clinical trials – current and controversial issues in design and analysis. Issue 2 (4th March 2018) Authors: Sun, Steven Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 2(2018) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs. (8th December 2019) Authors: Balogh, Erin P.; Bindman, Andrew B.; Eckhardt, S. Gail; Halabi, Susan; Harvey, R. Donald; Jaiyesimi, Ishmael; Miksad, Rebecca; Moses, Harold L.; Nass, Sharyl J.; Schilsky, Richard L.; Sun, Steven; Torrente, Josephine M.; Warren, Katherine E. Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: e405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib. (3rd May 2021) Authors: Balasubramanian, Sriram; Wang, Songbai; Major, Christopher; Hodkinson, Brendan; Schaffer, Michael; Sehn, Laurie H.; Johnson, Peter; Zinzani, Pier Luigi; Carey, Jodi; Shreeve, S. Martin; Sun, Steven; Gerecitano, John; Vermeulen, Jessica; Staudt, Louis M.; Wilson, Wyndham Journal: British journal of haematology Issue: Volume 194:Number 1(2021) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Design considerations in clinical trials with cure rate survival data: A case study in oncology. (20th November 2017) Authors: Sun, Steven; Liu, Grace; Lyu, Tianmeng; Xue, Fubo; Yeh, Tzu‐Min; Rao, Sudhakar Journal: Pharmaceutical statistics Issue: Volume 17:Number 2(2018) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies. Issue 1 (8th September 2015) Authors: Gayko, Urte; Fung, Mann; Clow, Fong; Sun, Steven; Faust, Elizabeth; Price, Samiyeh; James, Danelle; Doyle, Margaret; Bari, Samina; Zhuang, Sen Hong Journal: Annals of the New York Academy of Sciences Issue: Volume 1358:Issue 1(2015) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Early M‐Protein Dynamics Predicts Progression‐Free Survival in Patients With Relapsed/Refractory Multiple Myeloma. Issue 6 (17th July 2020) Authors: Yan, Xiaoyu; Xu, Xu Steven; Weisel, Katja C.; Mateos, Maria‐Victoria; Sonneveld, Pieter; Dimopoulos, Meletios A.; Usmani, Saad Zafar; Bahlis, Nizar J.; Puchalski, Thomas; Ukropec, Jon; Bellew, Kevin; Ming, Qi; Sun, Steven; Zhou, Honghui Journal: Clinical and translational science Issue: Volume 13:Issue 6(2020) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Estimands in hematologic oncology trials. (8th March 2021) Authors: Sun, Steven; Weber, Hans‐Jochen; Butler, Emily; Rufibach, Kaspar; Roychoudhury, Satrajit Journal: Pharmaceutical statistics Issue: Volume 20:Number 4(2021) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition. (27th April 2022) Authors: Sun, Steven; Pithavala, Yazdi K.; Martini, Jean‐François; Chen, Joseph Journal: Journal of clinical pharmacology Issue: Volume 62:Number 9(2022) Page Start: 1170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗